neuronal reprogramming PostDoc positions and fellowships

The Postdoctoral Fellow in Computational Systems Biology at CIC bioGUNE will develop a computational platform to design neuronal cell conversion protocols for Alzheimer's disease, stroke, and epilepsy therapies. The role combines gene network-based approaches with machine learning models to predict transcription factor combinations for generating specialized neuronal subtypes. The candidate will collaborate with international experimental teams under a Canadian NFRF grant, contributing to stem cell research, aging, and disease modeling within a dynamic, interdisciplinary environment.

This PhD position at the University of Barcelona focuses on developing innovative human-based in vitro and in silico brain models within the Horizon Europe MSCA VISI-ON-BRAIN doctoral network, investigating scaffold geometry and cell reprogramming effects on cortical progenitor proliferation, neuronal migration, and neurodevelopmental disorder models, and will enrol in the PhD programme while collaborating with international partners.

The Heinrich lab at SBRI (INSERM U1208) is seeking a postdoc scientist to explore lineage reprogramming for brain repair. The project focuses on converting glial cells into functional induced neurons to replace lost neurons and induce functional recovery following brain injury or disease. The successful candidate will work at the interface of neurosciences, cell biology, and transcriptomics, investigating molecular programs underlying cell identity conversion and assessing therapeutic impact in mouse models of epilepsy.

This PhD scholarship focuses on developing in vitro stem cell-derived neural tube models to investigate human midbrain-hindbrain boundary morphogenesis and teratogenesis using human pluripotent stem cell technology and 3D printing at DTU Bioengineering.

This post-doctoral fellowship in the School of Biomedical Sciences at the University of Hong Kong focuses on uncovering the molecular mechanisms underlying the evolution of animal multicellularity. The successful candidate will investigate transcription factor families that regulate pluripotent stem cells, employing biochemical assays, sequence analysis, and induced pluripotent stem cell (iPSC) technologies. Ideal applicants hold a Ph.D. in pluripotent stem cell biology, cellular reprogramming, or bioinformatics, with strong experimental and communication skills.

The Postdoctoral Associate position in the Feng Laboratory at Rutgers Cancer Institute focuses on independent laboratory research investigating tumor suppressor p53 regulation and its gain-of-function mutants in cancer, as well as the role of tumor suppressors in tumor microenvironment and tumor immunology. The role involves conducting experimental and bioinformatics studies, preparing reports and grant proposals, and presenting findings orally. Candidates must hold or be nearing completion of a PhD with a strong background in molecular biology and cancer biology, and will work full-time on-site in New Brunswick, New Jersey.

This postdoctoral associate position at Rutgers Cancer Institute’s Feng Laboratory focuses on investigating the regulation and function of tumor suppressor p53 and its gain-of-function mutants in cancer, as well as the role of p53 and its target genes in tumor microenvironment and tumor immunology. The role involves independent laboratory research, experimental and bioinformatics studies, grant writing, and presentations under the guidance of the principal investigator.

A postdoctoral scholar position is available at The Ohio State University in the Department of Neuroscience. The role focuses on researching interoception neuron circuits using zebrafish models, involving experimental design, data analysis, manuscript preparation, and collaboration across labs.

This post-doctoral fellowship focuses on establishing and optimizing protocols for differentiating motor neurons from patient‑derived induced pluripotent stem cells (iPSCs) and applying cutting‑edge single‑cell proteomics to uncover disease‑relevant protein signatures in neuronal development. The researcher will integrate proteomic data with transcriptomics and imaging, collaborate with clinical partners on Parkinson’s and Alzheimer’s disease, and gain hands‑on experience with state‑of‑the‑art mass spectrometry instrumentation and computational analysis within an international, collaborative research environment at the Luxembourg Institute of Health.

This 4-year PhD position at Delft University of Technology invites candidates to investigate the molecular assembly of neuronal synapses using cutting-edge cryo-electron tomography and complementary light microscopy. Working in Dr. Dimphna Meijer’s lab, the project aims to elucidate the nanoscale architecture of synaptic cell‑adhesion molecules and their functional implications in health and disease. The role combines hands‑on training in advanced structural biology techniques with opportunities for scientific independence within an international, supportive research environment.

This fully funded postdoctoral position at the University of Basel focuses on peripheral neuroscience and neuro-immune interactions within the Cancer Neuroimmunology lab led by Prof. Karen Dixon. The successful candidate will lead an interdisciplinary project investigating how peripheral neural signals regulate immune cell function in tissues and contribute to inflammatory or tumour-associated disease states. Research will employ neuronal tracing, in vivo disease models, genetic and viral manipulation of neuronal populations, imaging, flow cytometry, single‑cell RNA sequencing, spatial transcriptomics, and functional neuro‑immune assays.

This postdoctoral fellowship focuses on deciphering the neurotoxic mechanisms of chitinase 3-like 1 (CHI3L1) in progressive multiple sclerosis and identifying therapeutic compounds that block its pathogenic effects. The successful candidate will work within the Clinical Neuroimmunology Group at VHIR, utilizing human iPSC-derived neuronal models, molecular and cellular biology, advanced imaging, transcriptomic and proteomic approaches, and drug screening strategies to uncover intracellular mediators, neuronal receptors, and potential drug candidates for progressive MS therapy.